Ability Pharmaceuticals

Ability Pharmaceuticals is a biotech company in Cerdanyola del Vallès, Spain, founded in 2012. It has raised $8.6M across 2 rounds, most recently a $7.6M Growth Equity in July 2024.

- Ability Pharma

Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$8.6M
Last Round
$7.6M Growth EquityJul 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Ability Pharmaceuticals (AbilityPharma) is a clinical-stage biopharmaceutical company headquartered in Cerdanyola del Vallès (Barcelona), Catalonia, Spain, focused on developing first-in-class cancer therapies through autophagy induction. The company's lead compound, ABTL0812 (Ibrilatazar), is currently in a Phase 2b double-blind placebo-controlled clinical trial in 140 patients with metastatic pancreatic cancer across the USA, Spain, France, and Israel, and has shown positive results in Phase 2a trials for endometrial and lung cancer. AbilityPharma investigates drugs that selectively induce cytotoxic autophagy in cancer cells, targeting major oncological unmet needs with a novel mechanism of action.

Summary

It lists 11–50 employees. It has raised $8.6M in total across 2 rounds, most recently a $7.6M Growth Equity round in Jul 2024. Investors include CTI Life Sciences Fund, Inveready and European Innovation Council Fund.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Growth EquityGrowth EquityJul 2024
$7.6M

Sign up to see all 2 events

Funding: Seed through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ability Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/ability-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/ability-pharmaceuticals" alt="Ability Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>